Live Breaking News & Updates on Nfections

Stay informed with the latest breaking news from Nfections on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Nfections and stay connected to the pulse of your community

The Gap in Gum Care: Why Caring For Your Teeth's Foundation Matters

(NAPSI)—Building a great smile starts with a strong foundation. While gums are often overlooked unless they are bleeding or causing mouth pain, they are the key to good oral health, overall …

Washington , United-states , Americans , Nadiam-fugate , Centers-for-disease , Delta-dental , Disease-control , Gum-disease , Laucoma , Eart-disease , Igh-blood-pressure

Having surgery? Here's what patients can ask surgeons to help prevent a particularly harmful error | Lifestyle

When a surgeon accidentally leaves a surgical tool inside a patient’s body after a procedure, the harm can be severe. The patient can suffer from life-threatening infections, organ damage, and

Plymouth-meeting , Pennsylvania , United-states , Philadelphia , Marcus-schabacker , Carl-sirio , Philadelphia-inquirer , Temple-health , Tribune-content-agency , Surgery , Cri , Ncision

Recce Pharmaceuticals Announces Expansion of Phase I/II Trial of RECCE® 327 for the Treatment of Diabetic Foot Infections

Independent Safety Committee unanimously agrees that the Phase I/II trial is safe, well tolerated, and fit for expanded accessStudy achieving primary endpoints of safety, tolerability, and efficacy by resolving/curing bacterial infections in patients with diabetic foot ulcersRECCE® 327 dosed daily or every second day for 14 days is considered to be safe and well-toleratedAdditional clinical sites to be launched in Australia, and additional clinical trials will be launched internationally in diab

Australia , United-states , Sydney , New-south-wales , James-graham , Andrew-geddes , Michael-fitzhugh , Guillaume-van-renterghem , Hugh-dickson , Recce-pharmaceuticals-ltd , Safety-committee , Safety-committee-of-liverpool-hospital

Infection Control Resources to Mitigate Patient Exposure Risks to Klebsiella and Other Pathogens

An article published last year in Emerging Infectious Diseases detailed a notable increase of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in New York City during 2021 through June of 2022. The data for the study came from a large public healthcare system in New York City that serves more than 1.2 million people each year., , , , The Centers for Disease Control and Prevention (CDC) describes Klebsiella as a type of gram-negative bacteria that can cause different types of...

New-york , United-states , Florida , Frank-selamie , Paul-cochrane , Centers-for-disease , Consulting-testing-services-inc , Cochrane-associates , Infection-control-resources , Mitigate-patient-exposure-risks , Emerging-infectious-diseases , New-york-city

Nanoscale Engineers Receive $1.2 Million to Prevent Surface Pathogens

UT Battelle LLC, a management contractor for the U.S. Department of Energy’s (DOE) Office of Science, has awarded $1.2 million to Stony Brook University resea

Oak-ridge , North-carolina , United-states , Koga-endoh , Maya-endoh , Tadanori-koga , Biopreparedness-research-virtual-environment-bra , Us-department-of-energy , Office-of-science , Ut-battelle , Research-professor , Technical-state-university

Fox Chase researchers find new way to combat C. diff infections

Fox Chase Cancer Center researchers reveal the benefits and risks of using oral antibiotic vancomycin in cancer patients after stem cell transplants.

Philadelphia , Pennsylvania , United-states , Fox-chase , Fox-chase-cancer-center , Cell , Hase , Tem , Ox , Educed , Ntibiotic

How did they die? Nevada limits 'superbug' death data

As testing reveals more cases involving the "superbug" known as candida auris, the medical field is struggling with a tough question. Are people dying "from" C. auris, or are they just dying "with" C. auris?

Nevada , United-states , Neil-clancy , Healthcare-associated-infections-program , Nevada-division-of-public , University-of-pittsburgh , Division-of-public , Behavioral-health , Nevada-division , State-healthcare-associated-infections , Dr-neil-clancy , Andida-auris